Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.

S.M.W.Y. van de Ven, S.G. Elias, C.T. Chan, Z. Miao, A. De, S.S. Gambhir

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1073-1081
Number of pages9
JournalClinical Cancer Research
Issue number4
Publication statusPublished - 2012

Cite this